![baby glimpses bakersfield baby glimpses bakersfield](https://www.treehugger.com/thmb/Vsze-ak7w2K374oZQdRSW5tfmbg=/990x638/filters:no_upscale():max_bytes(150000):strip_icc()/__opt__aboutcom__coeus__resources__content_migration__mnn__images__2014__05__kitfoxsmell-39ce535bf2364e35a790fecf3b591cad.jpg)
So then I thought "what about someone looking for working class jobs?" So I decided to focus on restaurants- servers, hosting, etc. Out of 100, my applications with a female name got 45 responses to interview The female resume was 650% more likely to get a callback. Out of 100, my applications with a male name got 7 responses for interview. I'd send it out with my real name, then a few days later (or few days before) with a female name. So I took my CV and changed the name to a female name. It's MUCH better being a woman So I did an experiment, I work in CS and decided to test what the gender bias is. AllCells – Quality Cells for Quality Science™.29.6K 1.3K sent 100 applications as a man and a woman. Through experience and scientific expertise, AllCells maintains the best-in-class products and services with optimized protocols that ensure research and clinical-grade products are delivered on time to pharmaceutical, biotechnology, medical device, healthcare, and academic institutions around the world.īy consistently delivering high-viability, high-purity subtypes and guaranteeing an accurate cell count, AllCells has earned a reputation for high-quality cells with the ability to customize our product to meet even the most unique requirements. We are Science at your Service™! For more information, visit dls.com/cell-and-gene-therapy-products.įor over two decades, AllCells has been a leading provider of high-quality human primary blood and marrow-based cells. We offer one of the largest recallable donor pools, Research Use Only (RUO) and clinical-grade (GMP) fresh and cryopreserved human cellular materials to support cell and gene therapy programs at any scale from start to finish.ĭriven by leading scientific expertise and innovative use of current technologies, the Discovery team engages and consults with customers to rapidly overcome obstacles and obtain results to make critical research, development, and manufacturing decisions at market-leading speed. "Our solution delivers access to the entire continuum from RUO to GMP starting materials, informed by integrated, comprehensive characterization at scale, to support these rapidly expanding needs of the industry."ĭiscovery Life Sciences, the Biospecimen and Biomarker Specialists™, is a leading provider of highly characterized human cellular starting materials integrated with expert multi-omic analytical services to advance cell and gene therapy research, development, and manufacturing. "The promise of CGT to impact patient health is unquestionable, but improvements in manufacturing and reproducibility are needed to expand addressable patient populations and enhance treatment paradigms," said Discovery's Chief Technical Officer, CGT Dominic Clarke. Our strategy parallels and reinforces Discovery's 'Science at your Service' approach, and our unified offerings will further accelerate our clients' strategic and vital cell and gene therapy programs." By offering donor program consulting, high-quality apheresis collections, customization services, and GMP-compliant starting materials, our dedicated team will continue to provide a high-touch, client-focused approach to ensure our clients' needs are met with superior products and services to fit any timeline and on any scale. Zheng said, "We have built our organization to be an extension of our client's supply chain. This proximity strategically enables immediate processing and cryopreservation for unparalleled quality ― providing customers faster and more cost-effective access to a larger, engaged donor pool with characterization for client-specific programs. The FDA-registered donor collection facilities and GMP-compliant cleanrooms are located adjacent to characterization labs. The combination of Discovery's growing CGT business with AllCells also creates one of the industry's largest dedicated client donor pools. Effective immediately, AllCells CEO and President Danny Zheng will lead the combined entity.
![baby glimpses bakersfield baby glimpses bakersfield](https://i.etsystatic.com/isbl/d0afc1/18600852/isbl_480x120.18600852_p81co33f.jpg)
"Bringing these two great companies together creates a scalable, end-to-end solution that gives our clients unprecedented access to reliable human cellular starting materials with integrated multi-omic analytic services to support cell and gene therapies."ĭiscovery will combine its existing CGT products and services with AllCells to create a new business unit called AllCells, a Discovery Life Sciences Company. "We are very excited to welcome the AllCells team to the Discovery family," said Discovery CEO Glenn Bilawsky.